Correction to “Newly Synthesized Indolylacetic Derivatives Reduce Tumor Necrosis Factor-Mediated Neuroinflammation and Prolong Survival in Amyotrophic Lateral Sclerosis Mice”
Authors
- Vincenzo Santagada (ORCID: https://orcid.org/0000-0001-8377-8990)
- Beatrice Ulloa Severino (ORCID: https://orcid.org/0000-0002-3887-8869)
- Francesco Frecentese (ORCID: https://orcid.org/0000-0001-8821-2937)
- Elisa Perissutti (ORCID: https://orcid.org/0000-0002-1754-1191)
- Antonia Scognamiglio (ORCID: https://orcid.org/0000-0002-4282-2788)
- Rosa Sparaco (ORCID: https://orcid.org/0009-0003-4221-5560)
- Angela Corvino (ORCID: https://orcid.org/0000-0002-0617-156X)
- Giuseppe Caliendo (ORCID: https://orcid.org/0000-0002-5098-6045)
- Giuseppe Pignataro (ORCID: https://orcid.org/0000-0002-7290-4397)
- Serenella Anzilotti (ORCID: https://orcid.org/0000-0002-8729-0009)
- Michele Gargiulo
- Giorgia Andreozzi
- Ferdinando Fiorino
- Valeria Valsecchi
- Giovanna Lombardi
Publication Details
- Journal
- ACS Pharmacology & Translational Science
- Published
- 2026-02-02
- DOI
- https://doi.org/10.1021/acsptsci.6c00037
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00